The effects of synbiotic supplementation on hormonal status, biomarkers of inflammation and oxidative stress in subjects with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial

BMC Endocrine Disorders

Volumn 18, Issue 1, 2018, Pages

  Nasri, Khadijeh ^a   Jamilian, Mehri ^a   Rahmani, Elham ^a   Bahmani, Fereshteh ^b   Tajabadi Ebrahimi, Maryam ^c   Asemi, Zatollah ^b  

^a ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Hormonal status; Inflammation; Oxidative stress; Polycystic ovary syndrome; Synbiotic

Indexed keywords

C REACTIVE PROTEIN; GLUTATHIONE; INSULIN; MALONALDEHYDE; NITRIC OXIDE; PLACEBO; SEX HORMONE BINDING GLOBULIN; SYNBIOTIC AGENT; TESTOSTERONE; BIOLOGICAL MARKER; SEX HORMONE;

ANALYTICAL PARAMETERS; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FREE ANDROGEN INDEX; HORMONE DETERMINATION; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MODIFIED FERRIMAN GALLWEY SCORE; OVARY POLYCYSTIC DISEASE; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TOTAL ANTIOXIDANT CAPACITY; TREATMENT DURATION; ADULT; BLOOD; DIETARY SUPPLEMENT; ENDOCRINE SYSTEM; FOLLOW UP; IMMUNOLOGY; INFLAMMATION; PROGNOSIS;

ADULT; BIOMARKERS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ENDOCRINE SYSTEM; FEMALE; FOLLOW-UP STUDIES; GONADAL STEROID HORMONES; HUMANS; INFLAMMATION; OXIDATIVE STRESS; POLYCYSTIC OVARY SYNDROME; PROGNOSIS; SYNBIOTICS;

EID: 85045411060     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/s12902-018-0248-0     Document Type: Article

References (54)

1. Clark NM, Podolski AJ, Brooks ED, et al. Prevalence of polycystic ovary syndrome phenotypes using updated criteria for polycystic ovarian morphology: an assessment of over 100 consecutive women self-reporting features of polycystic ovary syndrome. Reprod Sci. 2014;21:1034-43.
2. Duleba AJ, Dokras A. Is PCOS an inflammatory process? Fertil Steril. 2012;97:7-12.
3. Boots CE, Jungheim ES. Inflammation and human ovarian follicular dynamics. Semin Reprod Med. 2015;33:270-5.
4. Akram Kooshki A, Tofighiyan T, Rakhshani MH. Effects of Synbiotics on inflammatory markers in patients with type 2 diabetes mellitus. Glob J Health Sci. 2015;7:1-5.
5. Ahmadi S, Jamilian M, Tajabadi-Ebrahimi M, et al. The effects of synbiotic supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes: a randomised, double-blind, placebo-controlled trial. Br J Nutr. 2016;116:1394-401.
6. Saez-Lara MJ, Robles-Sanchez C, Ruiz-Ojeda FJ, et al. Effects of probiotics and Synbiotics on obesity, insulin resistance syndrome, type 2 diabetes and non-alcoholic fatty liver disease: a review of human clinical trials. Int J Mol Sci. 2016;17:928.
7. Tanaka K, Yano M, Motoori M, et al. Impact of perioperative administration of synbiotics in patients with esophageal cancer undergoing esophagectomy: a prospective randomized controlled trial. Surgery. 2012;152:832-42.
8. Cani PD, Delzenne NM. Involvement of the gut microbiota in the development of low grade inflammation associated with obesity: focus on this neglected partner. Acta Gastroenterol Belg. 2010;73:267-9.
9. Bahmani F, Tajadadi-Ebrahimi M, Kolahdooz F, et al. The consumption of synbiotic bread containing lactobacillus sporogenes and inulin affects nitric oxide and malondialdehyde in patients with type 2 diabetes mellitus: randomized, double-blind, placebo-controlled trial. J Am Coll Nutr. 2016;35:506-13.
10. Ipar N, Aydogdu SD, Yildirim GK, et al. Effects of synbiotic on anthropometry, lipid profile and oxidative stress in obese children. Benef Microbes. 2015;6:775-82.
11. Lamprecht M, Bogner S, Schippinger G, et al. Probiotic supplementation affects markers of intestinal barrier, oxidation, and inflammation in trained men; a randomized, double-blinded, placebo-controlled trial. J Int Soc Sports Nutr. 2012;9:45.
12. Voltolini C, Battersby S, Etherington SL, et al. A novel antiinflammatory role for the short-chain fatty acids in human labor. Endocrinology. 2012;153:395-403.
13. Matthews GM, Howarth GS, Butler RN. Short-chain fatty acid modulation of apoptosis in the Kato III human gastric carcinoma cell line. Cancer Biol Ther. 2007;6(7):1051.
14. Rotterdam ESHRE. ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19-25.
15. Huang A, Brennan K, Azziz R. Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria. Fertil Steril. 2010;93:1938-41.
16. Ahmadi S, Jamilian M, Karamali M, et al. Probiotic supplementation and the effects on weight loss, glycaemia and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Hum Fertil (Camb). 2017;20:254-61.
17. Asemi Z, Jamilian M, Mesdaghinia E, et al. Effects of selenium supplementation on glucose homeostasis, inflammation, and oxidative stress in gestational diabetes: randomized, double-blind, placebo-controlled trial. Nutrition. 2015;31:1235-42.
18. Hatch R, Rosenfield RL, Kim MH, et al. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol. 1981;140:815-30.
19. Tatsch E, Bochi GV, Pereira Rda S, et al. A simple and inexpensive automated technique for measurement of serum nitrite/nitrate. Clin Biochem. 2011;44:348-50.
20. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem. 1996;239:70-6.
21. Beutler E, Gelbart T. Plasma glutathione in health and in patients with malignant disease. J Lab Clin Med. 1985;105:581-4.
22. Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med. 1990;9:515-40.
23. Pisprasert V, Ingram KH, Lopez-Davila MF, et al. Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans. Diabetes Care. 2013;36:845-53.
24. Asemi Z, Khorrami-Rad A, Alizadeh SA, et al. Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial. Clin Nutr. 2014;33:198-203.
25. Asemi Z, Foroozanfard F, Hashemi T, et al. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome. Clin Nutr. 2015;34:586-92.
26. Foroozanfard F, Jamilian M, Bahmani F, et al. Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. Clin Endocrinol. 2015;83:888-94.
27. Shoaei T, Heidari-Beni M, Tehrani HG. Effects of probiotic supplementation on pancreatic β-cell function and c-reactive protein in women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. International journal of preventive medicine. 2015;6:27.
28. Eslamparast T, Zamani F, Hekmatdoost A, et al. Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study. Br J Nutr. 2014;112:438-45.
29. Moroti C, Souza Magri LF, de Rezende Costa M, et al. Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus. Lipids Health Dis. 2012;11:29.
30. De Leo V, Musacchio MC, Cappelli V, et al. Genetic, hormonal and metabolic aspects of PCOS: an update. Reprod Biol Endocrinol. 2016;14:38.
31. Walters KA, Allan CM, Handelsman DJ. Androgen actions and the ovary. Biol Reprod. 2008;78:380-9.
32. Azzolin GC, Saiduddin S. Effect of androgens on the ovarian morphology of the hypophysectomized rat. Proc Soc Exp Biol Med. 1983;172:70-3.
33. Gonzalez F, Sia CL, Bearson DM, et al. Hyperandrogenism induces a proinflammatory TNFalpha response to glucose ingestion in a receptor-dependent fashion. J Clin Endocrinol Metab. 2014;99:E848-54.
34. Compare D, Coccoli P, Rocco A, et al. Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2012;22(6):471.
35. Li Z, Yang S, Lin H, et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology. 2003;37:343-50.
36. Eslamparast T, Poustchi H, Zamani F, et al. Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study. Am J Clin Nutr. 2014;99:535-42.
37. Asemi Z, Jazayeri S, Najafi M, et al. Effect of daily consumption of probiotic yogurt on oxidative stress in pregnant women: a randomized controlled clinical trial. Ann Nutr Metab. 2012;60:62-8.
38. Zamani B, Golkar HR, Farshbaf S, et al. Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. Int J Rheum Dis. 2016;19:869-79.
39. Cheng CP, Tsai SW, Chiu CP, et al. The effect of probiotic-fermented soy milk on enhancing the NO-mediated vascular relaxation factors. J Sci Food Agric. 2013;93:1219-25.
40. Ghoneim MA, Moselhy SS. Antioxidant status and hormonal profile reflected by experimental feeding of probiotics. Toxicol Ind Health. 2016;32:741-50.
41. Holma R, Kekkonen RA, Hatakka K, et al. Low serum enterolactone concentration is associated with low colonic lactobacillus-enterococcus counts in men but is not affected by a synbiotic mixture in a randomised, placebo-controlled, double-blind, cross-over intervention study. Br J Nutr. 2014;111:301-9.
42. Khani S, Motamedifar M, Golmoghaddam H, et al. In vitro study of the effect of a probiotic bacterium lactobacillus rhamnosus against herpes simplex virus type 1. Braz J Infect Dis. 2012;16:129-35.
43. Ebrahimi-Mameghani M, Sanaie S, Mahmoodpoor A, et al. Effect of a probiotic preparation (VSL#3) in critically ill patients: a randomized, double-blind, placebo-controlled trial (pilot study). Pak J Med Sci. 2013;29:490-4.
44. Pawelczak M, Rosenthal J, Milla S, et al. Evaluation of the pro-inflammatory cytokine tumor necrosis factor-alpha in adolescents with polycystic ovary syndrome. J Pediatr Adolesc Gynecol. 2014;27:356-9.
45. Valmadrid CT, Klein R, Moss SE, et al. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med. 2000;160:1093-100.
46. Filippone EJ, Gupta A, Farber JL. Normoglycemic diabetic nephropathy: the role of insulin resistance. Case Rep Nephrol Urol. 2014;4:137-43.
47. Lu HJ, Tzeng TF, Liou SS, et al. Polysaccharides from Liriopes Radix ameliorate streptozotocin-induced type I diabetic nephropathy via regulating NF-kappaB and p38 MAPK signaling pathways. BMC Complement Altern Med. 2014;14:156.
48. Kalina U, Koyama N, Hosoda T, et al. Enhanced production of IL-18 in butyrate-treated intestinal epithelium by stimulation of the proximal promoter region. Eur J Immunol. 2002;32:2635-43.
49. Vitali B, Ndagijimana M, Cruciani F, et al. Impact of a synbiotic food on the gut microbial ecology and metabolic profiles. BMC Microbiol. 2010;10:4.
50. Komers R, Anderson S. Paradoxes of nitric oxide in the diabetic kidney. Am J Physiol Renal Physiol. 2003;284:F1121-37.
51. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res. 2001;50:537-46.
52. Shakeri H, Hadaegh H, Abedi F, et al. Consumption of synbiotic bread decreases triacylglycerol and VLDL levels while increasing HDL levels in serum from patients with type-2 diabetes. Lipids. 2014;49:695-701.
53. Wang Y, Li Y, Xie J, et al. Protective effects of probiotic lactobacillus casei Zhang against endotoxin- and d-galactosamine-induced liver injury in rats via anti-oxidative and anti-inflammatory capacities. Int Immunopharmacol. 2013;15:30-7.
54. Zhai Q, Wang G, Zhao J, et al. Protective effects of lactobacillus plantarum CCFM8610 against acute cadmium toxicity in mice. Appl Environ Microbiol. 2013;79:1508-15.